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How T cells differentiate in the neonate may critically determine the ability of the infant to 
cope with infections, respond to vaccines and avert allergies. Previously, we found that 
naïve cord blood CD4+ T cells differentiated toward an IL-4-expressing phenotype when 
activated in the presence of TGF-β and monocyte-derived inflammatory cytokines, the 
latter are more highly secreted by infants who developed food allergy. Here, we show that 
in the absence of IL-2 or IL-12, naïve cord blood CD8+ T cells have a natural propensity 
to differentiate into IL-4-producing non-classic TC2 cells when they are activated alone, 
or in the presence of TGF-β and/or inflammatory cytokines. Mechanistically, non-classic 
TC2 development is associated with decreased expression of IL-2 receptor alpha (CD25) 
and glycolysis, and increased fatty acid metabolism and caspase-dependent cell death. 
Consequently, the short chain fatty acid, sodium propionate (NaPo), enhanced IL-4 
expression, but exogenous IL-2 or pan-caspase inhibition prevented IL-4 expression. 
In children with endoscopically and histologically confirmed non-inflammatory bowel 
disease and non-infectious pediatric idiopathic colitis, the presence of TGF-β, NaPo, and 
IL-1β or TNF-α promoted TC2 differentiation in vitro. In vivo, colonic mucosa of children 
with colitis had significantly increased expression of IL-4 in CD8+ T cells compared with 
controls. In addition, activated caspase-3 and IL-4 were co-expressed in CD8+ T cells in 
the colonic mucosa of children with colitis. Thus, in the context of colonic inflammation 
and limited IL-2 signaling, CD8+ T cells differentiate into non-classic TC2 that may con-
tribute to the pathology of inflammatory/allergic diseases in children.
Keywords: cD8+ T cell, glycolysis, fatty acid oxidation, caspases, il-4
sUMMarY
Inflammation limits IL-2 signaling and promotes differentiation of cord blood CD8+ T cells into an 
IL-4+ phenotype, requiring fatty acid metabolism and caspase activation. Such cells co-expressing 
activated caspase-3 and IL-4 can be identified in the mucosa of children with colitis.
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inTrODUcTiOn
Differentiation of naïve CD4+ T  cells into functionally distinct 
helper T cell (TH) lineages such as TH1 (IFN-γ), TH2 (IL-4), TH17 
(IL-17), and TFH (IL-21) cells and induced regulatory T  cells 
(iTreg) that express FOXP3 is shaped by the cytokine environ-
ment (1). This reflects the nature of local tissues (e.g., mucosal 
or systemic lymphoid), as well as innate immune inflammatory 
responses to pathogens and other stimuli (2). Similarly, naïve 
CD8+ T cells differentiate into TC1 (IFN-γ) and TC2 (IL-4) (3), 
TC17 (IL-17) (4), TFC (5), or FOXP3-expressing (TCREG) (6) cells 
in the presence of the appropriate cytokines.
Human neonates display differences in innate and adaptive 
immune cell phenotypes and functions compared with adults. 
Cord blood mononuclear cells stimulated with toll-like receptor 
agonists secrete less IFN-α and IL-12 but more IL-6, a cytokine 
shift that inhibits TH1 differentiation and may contribute to 
increased neonatal susceptibility to infection by intracellular 
pathogens and viruses (7). The intrinsic differentiation capac-
ity of cord blood CD8+ T cells is not impaired but differs from 
adults, with increased propensity to proliferation and cell death 
(8). Differentiation of neonatal CD8+ T  cells under inflamma-
tory conditions is not well understood but may be relevant to 
the infant’s response to infections and vaccines and susceptibility 
to diseases such as allergies. Increased inflammatory cytokine 
(IL-1β, IL-6, and TNF-α) production in cord blood in response 
to innate stimuli (9–11) and persistence of type 2/IL-4 immunity 
in the first year of life (12) have been associated with allergic sen-
sitization. Previously, we reported that TGF-β and inflammatory 
cytokines, the latter secreted in higher amounts by cord blood 
monocytes from infants who developed food allergy, suppressed 
IL-2 expression by human cord blood CD4+ T cells and promoted 
a non-classical IL-4 TH2-type phenotype in naïve CD4+ T cells 
and naïve natural regulatory CD4+ T cells (13). This prompted us 
to investigate the differentiation of naïve cord blood CD8+ T cells 
in the presence of inflammatory cytokines. We found that in the 
absence of IL-2 or IL-12, naïve cord blood CD8+ T cells have a nat-
ural propensity of differentiating into IL-4-producing non-classic 
TC2 cells, associated with decreased glycolysis and increased fatty 
acid metabolism and caspase-dependent cell death. Similar cells 
were identified in situ in the colon of children with endoscopically 
and histologically confirmed non-inflammatory bowel disease 
(IBD) and non-infectious pediatric idiopathic colitis (PIC).
MaTerials anD MeThODs
subjects
This study was carried out in accordance with the recommen-
dations of the International Ethical Guidelines for Research 
Involving Human Subjects. The protocols were approved by the 
Human Ethics Committees of Walter and Eliza Hall Institute, 
Barwon Health, Geelong, and Guangzhou Women and Children’s 
Medical Center (GWCMC). Legal guardians of all subjects gave 
written informed consent in accordance with the Declaration 
of Helsinki. Cord blood and colon biopsies were obtained from 
Barwon Infant Study (14) and hospitalized children at GWCMC 
(Ethics Number 2017072601). Children (n =  18) at GWCMC 
underwent colonoscopy and biopsy for the diagnostic evaluation 
of chronic abdominal pain, vomiting, or lower gastrointestinal 
bleeding (Table S3 in Supplementary Material). Colitis was 
identified endoscopically as having mucosal swelling, hyperemia, 
erosion, or ulceration and histologically as impaired epithelial 
integrity, increased lymphocytes and/or eosinophil [>20/HPF 
(high power field)] infiltrations. Control colonic biopsies were 
from children who displayed no features of colitis on colonoscopy 
and histology.
cD8+ T cell isolation and activation
Frozen cord blood mononuclear cells were thawed and surface 
stained with anti-TCRαβ, -CD4, -CD8a, -CD45RA, -CD25, 
-CD14, -CD16, and HLA-DR antibodies. Naïve CD8+ T cells (CD1
4−CD16−TCRαβ+CD4−CD8a+CD45RA+CD25−) were sorted by 
flow cytometry. Naïve CD8+ cells were activated with antihuman 
CD3/CD28 antibody microbeads (Life Technologies) at 1:1 ratio 
in the presence of recombinant human cytokines in IP5 medium 
[Iscove’s modified Dulbecco’s medium (Life Technologies) sup-
plemented with 5% pooled human serum, 2  mM glutamine, 
0.05  mM 2-mercaptoethanol, 100  U/ml penicillin, 100  µg/ml 
streptomycin, and 100 µM non-essential amino acids]. On day 3, 
cultures were supplemented with cytokine-containing fresh IP5 
medium. The final concentrations of cytokines used were as fol-
lows: IL-2 (200 U/ml), IL-4 (10 ng/ml), IFN-γ (10 ng/ml), IL-1β 
(10  ng/ml), TNF-α (10  ng/ml), and IL-6 (100  ng/ml). TGF-β 
was used at 5 ng/ml for IL-2 + TGF-β and at 1 ng/ml elsewhere. 
Short chain fatty acids were supplemented at 1 mM. Pan-caspase 
inhibitor QVD-Oph (50 µM) was added in some experiments at 
day 1 or day 3. On days 4–5, activated T cells were re-stimulated 
with PMA (100 ng/ml) and ionomycin (1 µM) in the presence of 
monensin (2 µM) for 5 h and stained intracellularly with anti-pS6, 
-T-bet, -GATA-3, -IFN-γ, -IL-4, and -IL-2 antibodies. Activated 
T cells were also surface stained with anti-CD25, CXCR3, CCR4, 
and CD103 antibodies. Microbeads were added before surface 
staining to calculate cell numbers. All antibodies were purchased 
from eBiosciences except as indicated.
Colonic biopsies were kept in 0.9% NaCl solution at 4°C 
overnight before being preprocessed into fine pieces, followed by 
gentle rotation in a 37°C water bath for 45 min in Hank’s balanced 
salt solution (Ca2+, Mg2+ free) supplemented with 10 mM HEPES 
(pH 7.2), 5% fetal bovine serum, 100  U/ml penicillin, 100  µg/
ml streptomycin, and 5 mM EDTA. Intraepithelial lymphocytes 
(IELs) were recovered by centrifugation, activated with PMA 
(100 ng/ml) and ionomycin (1 µM) in the presence of monensin 
(2 µM) for 5 h. Cytokine expression of CD8+ T cells were analyzed 
by surface and intracellular staining with anti-CD45, CD3, CD4, 
CD8a, γδ-TCR, and IFN-γ and IL-4 antibodies, respectively.
immunofluorescence staining of colonic 
Biopsies
Paraffin-embedded sections of colonic biopsies were depar-
affinized in xylene, rehydrated in decreasing concentrations 
of ethanol, and then heated in 0.01  M citric acid buffer (pH 
6.0) for 15 min at 95°C to reveal antigens. After deparaffiniza-
tion, sections were rinsed in blocking buffer (1× PBS/5% 
normal goat serum/0.3% Triton X-100) for 1  h at room 
temperature (RT) and then incubated sequentially with rab-
bit anti-human CD8 (1:100) (Abcam) overnight at 4°C, goat 
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anti-rabbit-IgG-Cy3 (1:500) (Abcam) for 1  h at RT, rabbit 
anti-human cleaved (Asp175) caspase-3 (Cell Signaling 
Technology) overnight at 4°C, goat anti-rabbit-IgG-Alexa Fluor 
488 (1:500) (Abcam) for 1 h at RT, and anti-human IL-4-APC 
(BioLegend) overnight at 4°C. The sections were mounted with 
a Vector Shield mounting solution containing 4′,6-diamidino-
2-phenylindole (H-1200, Vector). Washing three times with 1× 
PBS was performed between incubations. Immunofluorescence 
images were acquired with a Leica TCS SP8 confocal system 
(Leica Microsystems) using a 20×/0.75 dry objective lens and 
analyzed with Leica X image analysis software (Leica). Post-
acquisition processing (brightness, opacity, contrast, and color 
balance) was applied to the entire image and accurately reflects 
that of the original.
Metabolic assays
To measure glucose uptake, cells were first cultured in glucose-
free media for 2 h, followed by 30 min incubation at 37°C with 
30 µM 2-NBGD (Life Technologies) and flow cytometry analysis. 
The Glycolytic Cell-Based Assay Kit (Cayman Chemicals) was 
used to measure lactate secreted into the medium. Cells from day 
4 cultures were incubated at 5 × 105/ml in fresh IP5 media for 
20 h. To measure mitochondria membrane potential, cells were 
incubated at 37°C for 20 min with 100 nM Mitotracker Orange 
(Life Technologies), which stains mitochondria in live cells, and 
its accumulation, measured by flow cytometry, is dependent on 
membrane potential.
Metabolic extraction and gas 
chromatography–Mass spectrometry
CD8+ T cells (~0.5 × 106) that had been activated for 4 days in the 
presence of IL-2 or IL-6 and TGF-β as above were rapidly cooled 
in ice-cold PBS and centrifuged at 4°C. Chloroform (50 µl) was 
added to the cell pellet, followed by extraction with methanol: 
water (3:1, 200 µl) containing stable isotopically labeled internal 
standards (13C6-sorbitol, 13C5, 15N-valine). The samples were 
placed on ice for 10  min with intermittent vortexing, then 
centrifuged to pellet cell debris and proteins (14,000 rpm, 5 min, 
4°C). The supernatant was transferred to a clean tube containing 
Milli-Q water (100 µl), vortexed, then centrifuged (14,000 rpm, 
5 min, 4°C) to promote biphasic partitioning. The upper aqueous 
phase containing polar metabolites was evaporated to dryness 
under vacuum and chemically derivatized for analysis by gas 
chromatography–mass spectrometry at Metabolomics Australia 
(Melbourne, VIC, Australia). Derivatization, GC/MS analysis, 
and data processing were performed as previously described 
(15). After GC/MS peaks were annotated and quantified, inten-
sities (area under curve) were log-transformed and median-
normalized. For metabolites with multiple detectable peaks, all 
measurements were summed up for representation. The Student’s 
t-test was performed to compare metabolite abundances of the 
different treatments and P-values adjusted for multiple testing 
using the Benjamini–Hochberg method (16).
rna-seq analysis
Total RNA was isolated from naïve and day 4-activated CD8+ 
T  cells with the RNeasy Mini Kit (QIAGEN). Libraries were 
constructed as per the Illumina TruSeq Stranded Total RNA 
Sample Preparation kit and sequenced with Illumina NextSeq 
500. RNA-Seq data were quality assessed by FastQC (0.10.1).1 
Residual adapter sequences were removed from reads and bases 
with a Phred score <25 trimmed from the start and end of reads. 
Reads < 50 bp long were discarded (Trimmomatic [0.33]) (17). 
Trimmed reads were mapped to the human genome (hg19) using 
STAR (2.4.0h1) in two-pass mode with default parameters (18). 
Duplicates were removed using MarkDuplicates (1.99 [1563]) 
from Picard tools.2 Read counts were then summarized across 
genes (GENCODE v19) using featureCounts (1.4.6) (19).
Raw read counts were imported into the R (3.3.1) statistical 
computing environment and analyzed using functions provided 
by the limma (3.30.13) (20) and edgeR (3.16.5) Bioconductor 
(3.4) packages. Genes with less than one count per million (cpm) 
in at least ten samples were removed from subsequent analysis. 
Counts were then normalized using trimmed mean of M-values 
(21). The limma “voom” (22) function was applied to the nor-
malized counts to estimate the mean–variance relationship and 
generate precision weights for each observation, ready for linear 
modeling.
Gene-wise linear models were fitted to the “voom”-transformed 
log2 cpm to determine differences in gene expression between 
activated and naive CD8+ T  cells, accounting for individual 
to individual variation. Statistically significant differentially 
expressed genes were identified using empirical Bayes moderated 
t-tests (23), allowing for a mean–variance trend and performing 
robust empirical Bayes shrinkage of the gene-wise variances to 
protect against hypervariable genes (24). P-values were adjusted 
for false discovery rate using the Benjamini–Hochberg method 
(16). KEGG pathways from the C2 curated gene sets in the Broad 
Institute Molecular Signatures Database were interrogated using 
the “camera” competitive gene set testing method (25), which 
tests whether a set of genes is highly ranked relative to other genes 
in terms of differential expression, accounting for inter-gene 
correlation.
statistics
Statistics was performed with Prism 6 software (GraphPad 
Software). For paired comparisons, a P-value was calculated by 
Wilcoxon matched-pairs signed rank test. For unpaired com-
parisons, P-values were determined by Mann–Whitney U test. 
Correlations were determined by linear regression. P-values for 
multiple comparisons were adjusted by the Benjamini–Hochberg 
method (16).
resUlTs
naïve cord Blood cD8+ T cells respond 
Distinctly to lineage Differentiation 
cytokines
We first examined cytokine and transcription factor expression 
in flow-sorted naïve cord blood CD8+ T cells (Figure 1A) when 
1 http://www.bioinformatics.babraham.ac.uk/projects/fastqc.
2 https://github.com/broadinstitute/picard.
AB
C
FigUre 1 | Differentiation of naïve cord blood CD8+ T cells. (a) Flow sorting of naïve CD8+ T cells from thawed cord blood mononuclear cells; (B) intracellular 
expression of IFN-γ and IL-4 after activation of naïve CD8+ T cells with anti-CD3/CD28 microbeads (1:1) ± cytokines; (c) decreased expression of GATA-3 and T-bet 
after induction of IL-4 expression by IL-6 + TGF-β in CD8+ T cells compared with cells activated by IL-2 + IL-4 and IL-2 + TGF-β. Data are representative of n > 10 
donors, all showing similar results.
4
Zhang et al. Non-Classical TC2 Differentiation
Frontiers in Immunology | www.frontiersin.org April 2018 | Volume 9 | Article 879
they were activated under CD4+ TH differentiation conditions. 
In the presence of IL-2 ± IL-12, IL-6 + TGF-β, or IL-2 + TGF-
β CD8+ T  cells expressed IFN-γ, IL-4, or FOXP3, respectively 
(Figures 1B,C). IL-2 + IL-4 did not induce significant IL-4 expres-
sion, as for classic Th2 cells. Of note, IL-6 + TGF-β-induced IL-4 
expression was associated with decreased expression GATA-3 
and T-bet (Figure 1C). Thus, cord blood CD8+ T cells differenti-
ate under IL-12/TH1 and IL-2 + TGFβ/iTreg conditions similarly 
to CD4+ T cells, as we have shown previously (13). However, in 
contrast to classic Th2 differentiation, cord blood CD8+ T cells 
differentiated into IL-4 -expressing “TC2” cells in the presence of 
IL-6 + TGF-β, not IL-2 + IL-4, and this process was associated 
with decreased expression of the classic Th2 transcription factor 
GATA-3.
il-2 suppresses and TgF-β Promotes 
cord Blood Tc2 Differentiation
After activation via the CD3 and CD28, a small proportion 
(median 11%) of cord blood naïve CD8+ T cells expressed IFN-γ 
(Figure 2A). The proportion of CD8+ T cells expressing IFN-γ 
increased when cells were activated in the presence of IL-2 or 
IL-12, separately or together, or in combination with a range of 
other cytokines (Figure 2A), consistent with the key roles of IL-2 
and IL-12 in Tc1 differentiation. The dominant effect of IL-12 on 
IFN-γ expression was further evident in that it overcame suppres-
sion of IL-2-induced IFN-γ expression under classical CD4+ TH2 
(IL-2 + IL-4) or iTreg (IL-2 + TGF-β) conditions (Figure 2A).
High proportions of IL-4 expression were observed when CD8+ 
T cells were activated in the absence of cytokines, or in the presence 
AB
C
D
E
F G
FigUre 2 | Differentiation of naïve cord blood CD8+ T cells is modified by different combinations of cytokines. Differentiation of cord blood CD8+ T cells activated 
with anti-CD3/CD28 microbeads (1:1) ± cytokines in different individuals. Proportions of CD8+ T cells expressing (a) IFN-γ or (B) IL-4 after cells were activated in 
the presence of different cytokines. (c) Numbers of cells generated when naïve CD8+ T cells were activated in the presence of different cytokines, relative to IL-2 
alone. P-values between indicated groups were calculated by Kruskal–Wallis test and corrected for multiple comparison with Original FDR method of Benjamini 
and Hochberg. (D) Proportions of IFN-γ and IL-4-expressing CD8+ T cells after activation in the presence of inflammatory cytokines (n = 10). Effects of activation 
and TGF-β on IL-4 expression for cord blood (e,F) and adult (g) CD8+ T cells. P-values calculated by paired t-test.
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of IL-1β ± TGF-β, TNF-α ± TGF-β or IL-6 ± TGF-β, compared 
with in the presence of IL-2 (Figures  2B,D). Substantial IL-4 
expression was also observed when CD8+ T cells were activated 
by IL-12 ± IL-2 and IL-12 ± TGF-β (Figure 2B). Generally, the 
number of cells recovered at day 5, when CD8+ T  cells were 
activated in the absence of cytokines, or in the presence of IL-12, 
AB
FigUre 3 | TGF-β induces expression of mucosa-chemotactic molecules on CD8+ T cells. Surface expression of chemokine receptors CXCR3 and CCR4  
(a) and integrin CD103 (B) 4 days after activation of naïve CD8+ T cells under specified conditions (data are representative of n > 10 donors). P-values between 
indicated groups were calculated on matched pairs by Wilcoxon matched-pairs signed rank.
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IL-6 + TGF-β, was significantly decreased, compared with cells 
recovered in the presence of IL-2 (Figure 2C).
Given that cord blood CD8+ T cells expressed IFN-γ, FOXP3, 
or IL-4 when they were activated by combinations of IL-12, IL-2, 
or IL-1β/IL-6/TNF-α with TGF-β, respectively, we analyzed 
the contributions of TGF-β alone to IL-4 expression in CD8+ 
T cells. Expression of IL-4 was significantly increased when cord 
blood CD8+ T  cells were activated in the presence of TGF-β 
(Figures 2E,F). By contrast, TGF-β alone did not increase IL-4 
expression in naïve CD8+ T cells (isolated from buffy coat) from 
adult donors (Figure 2G).
TgF-β induces expression of Mucosa-
chemotactic Molecules on Differentiated 
cD8+ T cells
TGF-β has traditionally been regarded as an anti-inflammatory 
cytokine, as evidenced by its role to promote regulatory CD4+ 
and CD8+ T cell development in the presence of IL-2. However, 
we previously found that TGF-β, in combination with IL-1-β 
or TNF-α, induced non-classic CD4+ “TH2”/IL-4 cells from 
naïve cord blood CD4+ T cells (13). In cord blood CD8+ T cells, 
TGF-β induced TC1 development in combination with IL-12, 
but TGF-β alone, or in combinations with IL-1β/TNF-α/IL-6 
induced “TC2” development (Figure 2). TGF-β is expressed by 
many cell types, including constitutively by lung stromal and gut 
epithelia cells involved in allergic asthma and food allergy, and 
is chemo-attractive for innate lymphoid type 2 cell trafficking 
(26). We therefore further investigated a role for TGF-β in CD8+ 
T  cell trafficking. First, we examined whether the chemokine 
receptors CXCR3 and CCR4 expressed by CD4+ TH1 or TH2 cells, 
respectively, were present on CD8+ T cells that express IFN-γ or 
IL-4. Expression of CXCR3 was decreased by IL-4 (Figure 3A; 
left panel). On the other hand, TGF-β consistently induced 
expression of CCR4 (Figure 3A; right panel) and alpha E integrin 
(CD103) (Figure 3B), irrespective of the CD8+ T cell phenotype.
cD8+ T cell Differentiation is conditioned 
by il-2-il-2r signaling
Previously, we found that suppression of IL-2 by inflammatory 
cytokines and TGF-β was required for IL-4 expression by acti-
vated cord blood CD4+ T cells (13). In contrast to CD4+ T cells, 
activated cord blood CD8+ T cells expressed significantly less IL-2 
(Figure 4A). This suggests that cord blood CD8+ T cells may be 
poised to default toward “TC2” differentiation. Because IL-2 was 
critical for induction of TC1 but suppressed “TC2” differentiation, 
we examined the relationship between IL-2 receptor expression 
and CD8+ T cell differentiation. Expression of the IL-2 receptor 
alpha chain (IL-2RA) (CD25) was increased in the presence of 
AC
B
FigUre 4 | CD8+ T cell differentiation is determined by IL-2–IL-2R signaling. (a) Expression of IL-2 in activated CD4+ and CD8+ T cells at day 5. (B) Expression of 
IL-2 receptor alpha chain CD25 on day 4 after activation of CD8+ T cells in the presence of different cytokines. (c) Under anti-CD3/CD28, IL-6 and IL-6 ± TGF-β TC2 
conditions, decreased expression of CD25 correlates with increased expression of IL-4 (upper panel); under IL-2 + IL-6, IL-12, IL-2 + IL-12 TC1 conditions, 
decreased expression of CD25 correlates with increased expression of IFN-γ (lower panel).
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IL-2 and/or IL-12 but not IL-6 ± TGF-β “TC2” (IL-4) conditions 
(Figure 4B). When naïve CD8+ T cells from different individu-
als were activated alone or under “TC2” (IL-6) conditions, the 
decrease in CD25 expression was associated with an increase in 
IL-4 and decrease in IFN-γ expression. The reciprocal associa-
tion of CD25 and IL-4 persisted under IL-6 + TGF-β conditions 
(Figure  4C). By contrast, under TC1 (IL-2  +  IL-6, IL-12, or 
IL-2 + IL-12) conditions, the decrease in CD25 expression was 
associated with the increase in IFN-γ expression (Figure  4C). 
These findings illustrate how intrinsic IL-2 receptor signaling dif-
ferentially regulates T cell differentiation in cord blood according 
to the cytokine milieu.
Differentiation of “Tc2” cells is associated 
With Decreased glycolysis
TC1 activation is known to be associated with an increase in 
 aerobic glycolysis, dependent on IL-2 (27–29). On the other hand, 
naïve and memory T cell activation have been linked to fatty acid 
oxidation (30). To investigate the metabolic program under “TC2” 
conditions, we measured cell size, glucose uptake, lactate secretion 
and phosphorylation of the mTOR substrate ribosomal protein 
S6, each known to increase with glycolytic activity (31). In CD8+ 
T cells activated under “TC2” compared with IL-2/TC1 conditions 
all these parameters of glycolysis were decreased (Figures 5A–D). 
Notably, IL-4-positive cells had the lowest expression of phos-
phorylated S6 compared with IL-4-negative cells (Figure  5D). 
Inhibition of glycolysis was also confirmed by direct measurement 
of intracellular metabolites. At day 4, compared with activation 
in the presence of IL-2, CD8+ T cells activated in the presence of 
IL-6 + TGF-β had decreased intermediary glycolytic (fructose-
6-phosphate, 3-phosophoglycerate, phosphoenol pyruvate) and 
tricarboxylic acid cycle (citrate, fumarate, and malate) metabo-
lites. Downregulation of citrate, a biosynthetic precursor of fatty 
acid synthesis (FAS), suggests that IL-4 expression in CD8+ 
T  cells might depend on an alternative energy source. Indeed, 
AD
E
B C
FigUre 5 | Differentiation of “TC2” cells is associated with decreased glycolysis. Cell size (a), glucose uptake (B) and secretion of lactate (c) after activation of 
CD8+ T cells under TC1 or “TC2” conditions. All parameters of glycolysis were decreased under “TC2” conditions. (D) Decreased phosphorylation of S6, an mTOR 
substrate, associated with expression of IL-4. (e) Metabolites in CD8+ T cells that were activated under TC1/IL-2 and IL-6 + TGF-β/“TC2” conditions. Data are 
representative of three independent experiments.
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the concentrations of short-chain fatty acids (SCFAs), propionic 
acid, butyric acid, β-hydroxybutyric acid, and hexanoic acid were 
significantly increased with IL-6 + TGF-β, indicating a shift in 
fatty acid oxidation (Figure 5E).
“Tc2” Differentiation is associated With 
increased expression of lipid Metabolism 
genes and is caspase Dependent
To gain insight into mechanisms underlying “TC2” differentiation, 
we examined transcriptional profiles by RNA-Seq of naïve cord 
blood CD8+ T cells before and 4 days after activation in the pres-
ence of IL-6 + TGF-β (Figure S1 and Table S1 in Supplementary 
Material). Four hundred fifty-seven genes were significantly 
(FDR < 1%) differentially expressed by more than twofold in either 
direction. The decreased expression of MYC (27) and HIF1A (32) 
is consistent with inhibition of glycolysis. For several reasons, 
the increased expression of AHRR, BATF3–BATF–IRF4, and the 
decreased expression of BACH2, could also be consistent with the 
“TC2” phenotype. Thus, the product of AHRR (aryl hydrocarbon 
receptor repressor) is highly expressed in immune cells of the 
skin and intestine and its expression in mouse CD4+ T cells is 
induced by IL-6 + TGF-β (33). The BATF–IRF4 complex binds to 
AP-1 motifs and augments IL-4 expression, while BACH2–BATF 
antagonizes the recruitment of BATF–IRF4. In the mouse, IL-4 
increases the expression of Batf and Irf4 and decreases the expres-
sion of Bach2 (34) (Figure  6A). Although GATA3 mRNA was 
increased at day 4, we did not observe any increase in its protein 
expression by day 5 when IL-4 was expressed.
To identify signaling pathways associated with “TC2” dif-
ferentiation, we examined whether KEGG pathways from the 
Broad Institute Curated gene sets were enriched for differential 
expression (Table S2 in Supplementary Material). We observed 
significant enrichment of upregulated genes in pathways involved 
in fatty acid metabolism (Figure S2 in Supplementary Material). 
This was consistent with the increase in intracellular SCFAs as 
described earlier (see Figure  5E). The ribosome biogenesis 
pathway was, however, significantly enriched for downregulated 
genes (Figure S3 in Supplementary Material). Given that colonic 
bacteria ferment undigested complex carbohydrates to SCFAs, 
we postulated that with limited IL-2 signaling and decreased 
glycolysis, CD8+ T  cells would utilize SCFAs to produce IL-4. 
Indeed, supplementation with the SCFAs sodium propionate 
(NaPo) increased IL-4 expression when naïve CD8+ T cells were 
activated in the presence of IL-6 (Figure 6B).
Disruption of ribosome biogenesis and protein translation 
is known to inhibit CD8+ T cell proliferation (35) and promote 
caspase-dependent cell death (36). We consistently observed 
decreased cell numbers under “TC2” conditions (see Figure 2C). 
This was in part due to increased cell death when CD8+ T cells 
were activated under “TC2” conditions. In fact, at day 5 CD8+ 
T cells activated and differentiated to “TC2” cells in the presence 
of IL-6 + TGF-β were smaller and had reduced mitochondrial 
membrane potential compared with CD8 + T  cells activated 
with IL-2 (Figures 6C,D). The pan-caspase inhibitor QVD-Oph 
prevented cell death and, surprisingly, also completely inhibited 
IL-4 expression (Figure 6D). The caspase-dependent expression 
of IL-4 was specific as IFN-γ expression was not decreased 
but rather increased with IL-12 in the presence of QVD-Oph 
(Figure 6E).
“Tc2” Differentiation is increased 
in colonic Mucosa of children With 
idiopathic colitis
To obtain evidence that inflammation could promote differ-
entiation of non-classic “TC2” cells in  vivo, we first examined 
if naïve CD8+ T  cells from blood of children with idiopathic 
colitis were able to produce IL-4 under conditions that mimic 
colonic inflammation. We found that TGF-β and NaPo, together 
with IL-1β or TNF-α, promoted IL-4 expression in CD8+ T cells 
in vitro (Figure 7A). We then measured IL-4 and IFN-γ secre-
tion by colonic mucosal IELs derived from colonic biopsies, 10 
of which were reported as non-IBD and non-infectious PIC and 
8 as normal (Table S3 in Supplementary Material; Figure  7B). 
After activation of IELs with PMA and ionomycin, expression of 
IL-4 was significantly increased in PIC compared with controls 
(Figure 7C), but IFN-γ expression was not statistically different 
between the groups (Figure 7D). To relate IL-4 expression with 
caspase-dependent cell death, we performed immunofluores-
cence staining on formalin-fixed, paraffin-embedded sections 
of colonic biopsies, which revealed co-expression of IL-4 with 
activated caspase-3 in CD8+ T cells (Figure 7E).
In summary, induction of IL-4 expression in cord blood CD8+ 
T cells is associated with suppression of IL-2 receptor signaling 
and glycolysis, increased fatty acid metabolism, caspase activa-
tion and cell death. These findings provide a plausible explanation 
for the appearance of CD8+IL-4+ IELs present in children with 
colitis.
DiscUssiOn
Consistent with classical patterns of cytokine-induced Th1 and 
Treg differentiation as observed in CD4+ T cells, naïve cord blood 
CD8+ T cells differentiated into TC1 and TCREG lineages character-
ized by expression of IFN-γ and FOXP3, respectively. By contrast, 
IL-4 failed to induce classical IL-4-expressing (TC2) CD8+ T cells. 
However, substantial IL-4 expression was observed when cord 
blood CD8+ T cells were activated alone, with TGF-β, or com-
binations of inflammatory cytokines (IL-1β/IL-6/TNF-α, IL-12) 
with TGF-β or NaPo. These non-classical, IL-4-expressing CD8+ 
T  cells displayed decreased glycolysis but increased expression 
of the genes associated with fatty acid metabolism. Intriguingly, 
expression of IL-4 was caspase dependent and associated with 
increased cell death. These findings mirror those we reported 
for cord blood CD4+ T  cells, after observing that infants who 
developed food allergy had an increase in inflammatory cytokine 
expression by activated monocytes in their cord blood (13).
IL-2 is produced mainly by activated CD4+ T  cells and, via 
the high affinity IL-2R, maintains Myc (37) expression in CD4+ 
and CD8+ T cells, enhances transcription of genes for glycolysis, 
and promotes TH1 and TC1 differentiation (38). Limiting IL-2 
signaling upregulates expression of Bcl6, inhibits glycolysis (29), 
and results in loss of mitochondria membrane potential and 
AC D E
B
FigUre 6 | Differentiation of “TC2” cells is associated with increased fatty acid metabolism and is caspase dependent. (a) Mean-difference plot showing changes 
in gene expression associated with “TC2” differentiation. (B) IL-4 expression is increased with supplementation of sodium propionate (NaPo) (right). (c) Decreased 
mitochondrial membrane potential (MitoTracker-Orange stain) and cellular size in live “TC2” compared with TC1 cells. Data are representative of n > 10 donors, 
all with similar results. (D) Prevention of cell death and IL-4 expression at day 5 by the caspase inhibitor QVD-Oph added at day 0 and supplemented at day 3. 
(e) Enhancement of IFN-γ expression at day 5 by the caspase inhibitor QVD-Oph added at day 0 and supplemented at day 3. P-values were calculated by 
Wilcoxon matched-pairs signed rank test. 
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caspase-dependent cell death (39). The release of self-antigens 
(e.g., DNA) from apoptotic cells may elicit unwanted inflam-
mation. In this regard, activation of caspases 9, 3, and 7 follow-
ing apoptotic cell death has been shown to actively suppress 
inflammation (40). It is conceivable that activated caspases 
in pre-apoptotic CD8+ T  cells might also unleash a yet to be 
defined translational suppression mechanism of IL-4 (41). In 
fact, caspase-dependent expression of IL-4 could represent a 
default mechanism for apoptosis-associated immune suppression 
through the differentiation of anti-inflammatory macrophages 
and inhibition of type 1 immune responses (42). Indeed, IL-4 
expression has been previously observed in T cells, monocytes, 
neutrophils and bronchial epithelial cells undergoing cell death 
(43–45). In the face of elevated or sustained inflammatory condi-
tions, over-expression of IL-4 may, however, result in immune 
pathology. In fact, we found that IL-4 expression by colonic 
CD8+ IELs was significantly increased in children with colitis 
compared with control subjects. Furthermore, cell death may 
AB
E
C D
FigUre 7 | “TC2” differentiation is increased in colonic mucosa of children with colitis. (a) “TC2” differentiation in naïve CD8+ T cells isolated from children with 
non-inflammatory bowel disease and non-infectious pediatric idiopathic colitis (PIC). (B) Representative endoscopic images of colonic mucosa from control children 
and children with PIC. (c,D) Intracellular expression of IL-4 and IFN-γ in CD8+ intraepithelial lymphocytes from colonic mucosa following stimulation with PMA and 
ionomycin. P-value was calculated by Mann–Whitney U test. (e) Expression in situ of CD8, activated caspase-3, and IL-4 in paraffin-embedded sections of colonic 
biopsies. Data are representative of n > 3 independent experiments.
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promote the release of DNA and associated self-antigens, leading 
to the IL-4 dependent generation of IgE-specific autoantibodies, 
as described in systemic lupus erythematosus (46). Interestingly, 
administration of low-dose IL-2 markedly decreased disease 
severity in patients with SLE (47). Our demonstration that 
limiting IL-2 signaling is necessary for caspase-dependent IL-4 
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expression, suggests that administration of IL-2 might potentially 
alleviate immune-allergic diseases in children.
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